One-Stop Core TRuC-T Development Services

Online Inquiry

Background Service What We Can Offer Workflow Specialty Services Highlights FAQs Contact

Creative Biolabs provides One-Stop Core TRuC-T Development Services to address key limitations in next-generation T-cell therapies, including cytokine release syndrome–associated toxicity, limited persistence in solid tumors, and baseline tonic signaling that drives premature cellular exhaustion. Through a proprietary T cell receptor fusion construct (TRuC) platform that integrates antigen-binding domains directly into the intact TCR/CD3 complex, our services enable a more physiological T-cell signaling profile and improved functional durability. This approach delivers safer and more consistent anti-tumor activity while supporting the development of highly potent TRuC-T therapeutics with enhanced clinical translatability.

Introduction

TRuC-T cells integrate an antigen-binding domain directly into native T-cell receptor subunits, enabling activation through the complete endogenous TCR complex. Early studies demonstrated that TRuC architectures drive potent tumor cell killing while preserving physiological TCR signaling. Subsequent reports in oncoImmunology further confirmed robust antitumor activity of mesothelin-directed TRuC-T cells in solid tumor models. Together, these studies support TRuC-T as a promising next-generation T-cell therapy platform.

Service

Creative Biolabs provides a suite of solutions designed to move your TRuC-T candidates from theoretical design to validated lead. By leveraging the natural sensitivity of the entire TCR complex, we deliver therapeutic constructs that exhibit potent cytotoxicity with reduced pro-inflammatory cytokine secretion.

Key deliverables and problem-solving capabilities include:

Optimized TRuC receptor design and expression cassettes compatible with full TCR complex signaling.
Stable and reproducible generation of TRuC-T cells from human primary T cells.
Quantitative functional profiling, including antigen-specific activation, cytotoxicity, cytokine release, and exhaustion phenotyping.
Comparative benchmarking of multiple TRuC formats to support rational lead selection.
Preclinical-ready efficacy datasets suitable for internal decision-making and regulatory preparation.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Creative Biolabs delivers a TRuC-T development platform built on widely accepted and non-proprietary technology frameworks, including:

Analysis of One-Stop Core TRuC-T Development. (Creative Biolabs Original)

Our Workflow

To initiate our high-end development service, clients typically provide target antigen information, along with binder sequences (existing scFv or single-domain antibody sequences or clearly defined requirements for de novo binder discovery).

Workflow of One-Stop Core TRuC-T Development. (Creative Biolabs Original)

Specialty Services

TRuC Target Binder Design & Affinity Engineering

Creative Biolabs specializes in designing high-affinity TRuC binders, optimizing antigen recognition, and engineering precise binding domains to enhance specificity, ensuring your T cell therapies achieve maximal target engagement and therapeutic potential.

TRuC Construct Assembly & T Cell Engineering

We provide end-to-end TRuC construct assembly and T cell engineering, integrating your binder into customized constructs, optimizing expression, and producing functional T cells ready for preclinical development and advanced immunotherapy applications.

TCR/CD3 Integration & Phenotype Analysis

Our team ensures seamless TCR/CD3 incorporation into engineered T cells, performing detailed phenotypic profiling to validate surface expression, signaling competence, and functional readiness for potent immune responses in research or translational studies.

HLA-Independence & Potency Functional Analysis

Creative Biolabs evaluates TRuC-T cell efficacy across diverse HLA contexts, conducting potency assays to confirm cytotoxic activity, cytokine secretion, and HLA-independent functionality for reliable therapeutic performance.

Core Benefits

Fully integrated TRuC-T development service from target selection, binder optimization, construct design, to preclinical validation.
Customizable receptor engineering solutions tailored to your antigen, disease model, and functional requirements.
Flexible vector delivery and T-cell production platforms, including primary T cells and scalable manufacturing workflows.
Strict quality control standards, including reproducibility, sterility, and phenotypic validation throughout the development process.

FAQs

Q1: How do TRuC-T cells differ from second-generation CAR-T cells?

A1: TRuC-T cells integrate into the entire TCR complex, utilizing all six subunits for signaling, whereas CAR-T cells only use isolated CD3 zeta and co-stimulatory domains. This leads to more physiological signaling and less cytokine-related toxicity.

Q2: Can the TRuC platform be used for bispecific targeting?

A2: Yes. We can construct bispecific TRuC-T cells to prevent antigen escape, a common cause of relapse in therapies targeting a single antigen.

Q3: Does the TRuC integration interfere with the natural TCR's function?

A3: Research indicates that TRuC expression does not impair the T-cell's ability to respond to its original virus-specific TCR, maintaining the functional integrity of the cell.

Q4: Is the platform applicable to solid tumors?

A4: TRuC-T cells have shown potent activity against solid tumor targets, often outperforming CAR-T cells in tumor penetration and persistence.

Partner with Us

Creative Biolabs offers a complete, end-to-end solution for One-Stop Core TRuC-T Development Services, providing the technical expertise to turn complex biological challenges into viable therapeutic leads. From subunit optimization to in vivo models, we ensure your project benefits from the most sophisticated TCR-engineering platform available today. Unlike standard CAR-T cells that rely on isolated CD3 zeta chains, our TRuC-T cells utilize the entire TCR signaling machinery, providing a more balanced immune response. For detailed project discussions or to receive a technical proposal, feel free to contact us.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.